Prescribing by GP age

Christopher Harrison1, Joan Henderson, Helena Britt

  • 1Family Medicine Research Centre, University of Sydney, New South Wales, Australia.

Insights

Younger general practitioners (GPs) and older GPs exhibit distinct prescribing patterns. Understanding these differences is crucial for Australia's evolving medical workforce and patient care needs.

Area of Science:

  • Medical Workforce Research
  • General Practice
  • Health Services Research

Background:

  • Australia's medical workforce is expanding to address the healthcare needs of an aging population.
  • A demographic shift is occurring, with younger general practitioners (GPs) set to replace retiring older GPs.
  • Understanding practice differences between GP age groups is essential for workforce planning.

Purpose of the Study:

  • To compare the characteristics and clinical activities of younger GPs (aged <40) and older GPs (aged 60+).
  • To specifically investigate differences in prescribing behaviors between these two GP cohorts.
  • To inform strategies for managing the Australian medical workforce transition.

Main Methods:

  • Utilized data from the Bettering Health professional practice (BEACH) program.
  • Analyzed records from April 2009 to March 2012.
  • Compared a cohort of 439 younger GPs with 697 older GPs.

Main Results:

  • Identified significant differences in prescribing patterns between younger and older general practitioners.
  • Prescribing variations were observed, necessitating further detailed analysis (as indicated in Table 1).
  • The study provides empirical evidence on age-related practice variations in Australian general practice.

Conclusions:

  • Younger and older GPs demonstrate divergent approaches to patient management, particularly in prescribing.
  • These findings highlight the need for tailored continuing professional development and support for different GP age groups.
  • Addressing these prescribing differences is vital for maintaining high-quality patient care during workforce generational shifts.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...